Abstract:ABSTRACT Canine distemper virus (CDV) poses a severe threat to both domesticated and wild animals, including multiple carnivores. With the continued expansion of its host range, there is an urgent need for the development of a safer and more effective vaccine. In this study, we developed subunit vaccines based on a bacterium-like particle (BLP) delivery platform containing BLPs-F and BLPs-H, which display the CDV F and H glycoprotein antigens, respectively, using the antigen-protein anchor fusions produced by a recombinant baculovirus insect cell expression system. The combination of BLPs-F and BLPs-H (CDV-BLPs), formulated with colloidal manganese salt [Mn jelly (MnJ)] adjuvant, triggered robust CDV-specific antibody responses and a substantial increase in the number of interferon gamma (IFN-γ)-secreting CD4 + and CD8 + T cells in mice. Dogs immunized intramuscularly with this vaccine not only produced CDV-specific IgG but also displayed elevated concentrations of IFN-γ and interleukin 6 in their serum, along with an increase of the CD3 + CD4 + and CD3 + CD8 + T cell subsets. Consequently, this heightened immune response provided effective protection against disease development and reduced viral shedding levels following challenge with a virulent strain. These findings suggest that this BLP-based subunit vaccine has the potential to become a novel canine distemper vaccine. IMPORTANCE Many sensitive species require a safe and effective distemper vaccine. Non-replicating vaccines are preferred. We constructed subunit particles displaying canine distemper virus (CDV) antigens based on a bacterium-like particle (BLP) delivery platform. The CDV-BLPs formulated with theMn jelly adjuvant induced robust humoral and cell-mediated immune responses to CDV in mice and dogs, thereby providing effective protection against a virulent virus challenge. This work is an important step in developing a CDV subunit vaccine.

Adjuvant effects of recombinant giant panda (Ailuropoda melanoleuca) IL-18 on the canine distemper disease vaccine in mice.

Development and efficacy evaluation of remodeled canine parvovirus-like particles displaying major antigenic epitopes of a giant panda derived canine distemper virus

The Immunogenicity of CO-expressing Plasmid and Fusion Genes Plasmid Containing IBDV VP2/4/3 and ChIL-18 Genes

IL-17 As a Molecular Adjuvant on Enhancing Cellular Immune Responses to HIV DNA Vaccination

Risk of canine distemper virus vaccination of domestic dogs in giant panda habitat to giant pandas

Study of Clinical Adjuvant Therapy Effect of Canine Distemper Using Traditional Chinese Medicine

Increasing a robust antigen-specific cytotoxic T lymphocyte response by FMDV DNA vaccination with IL-9 expressing construct.

Canine distemper viral infection threatens the giant panda population in China

IL-17 As an Adjuvant Enhances Immune Responses of Recombinant Protein Vaccine

Fatal canine distemper virus infection of giant pandas in China

Immunogenicity and protective efficacy of a novel bacterium-like particle-based vaccine displaying canine distemper virus antigens in mice and dogs

Adjuvant effect of E515-A on porcine epidemic diarrhea virus inactivated vaccine

Vaccination at different anatomic sites induces different levels of the immune responses.

Outbreak and genotyping of canine distemper virus in captive Siberian tigers and red pandas

Impacts of canine distemper virus infection on the giant panda population from the perspective of gut microbiota

Crystal structure of the giant panda MHC class I complex: First insights into the viral peptide presentation profile in the bear family

Evaluation of the Safety and Immunogenicity of a Multiple Epitope Polypeptide from Canine Distemper Virus (CDV) in Mice

Nueleotide Seqnecnce Analysis of the H Aem Agglutinin Protein Gene of Giant Panda Strain of Canine Distemper Virus

[Preparation of a bacteriocidic serum protein (properdin)].

Immune Enhancing Effects of Recombinant Bovine IL-18 on Foot-and-mouth Disease Vaccination in Mice Model

Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virus